Table 3.
Age Class (Number of Patients) |
MFS Patients n (%) |
Asymptomatic Controls n (%) |
---|---|---|
<15 years (n = 7) | 0.86 ± 0.33 | 1.21 ± 0.23 |
15–29 years (n = 25) | 1.10 ± 0.40 | 1.20 ± 0.28 |
30–44 years (n = 21) | 1.41 ± 0.47 | 1.25 ± 0.29 |
45–59 years (n = 31) | 1.69 ± 0.54 | 1.57 ± 0.36 |
≥60 years (n = 6) | 1.61 ± 0.44 | 1.38 ± 0.62 |
Total (n = 90) | 1.39 ± 0.55 | 1.38 ± 0.40 |
The p-value was not significant for any comparison.